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EFFECTS OF CRYOPRESERVATION ON RECOMBINANT CHO CELL LINES 
 




Cryopreservation provides the foundation for research, development, and manufacturing operations in the CHO-
based biopharmaceutical industry. In spite of its criticality, studies are lacking that explicitly demonstrate that the 
routine cell banking process and potential freeze-thaw associated stress and damage during cryopreservation 
and recovery have no lasting detrimental effect on CHO cells. Statistics on cell-specific productivity (Qp) levels 
over time for GS-CHO cells generated using GS selectable marker and maintained under MSX selective 
pressure are also scarce. To address these gaps, we evaluated the impact of freeze-thaw on 24 recombinant 
GS-CHO cell lines (expressing one of three mAbs) using a series of production assays. Across our panel of cell 
lines, freeze-thaw did not result in any significant impact beyond the initial post-thaw passages. Production 
cultures sourced from cryopreserved cells and their non-cryopreserved counterparts yielded similar performance 
(in terms of growth, viability, and productivity), product quality (in terms of size, charge, and glycan distributions), 
and flow cytometric profiles (in terms of intracellular mAb expression). However, many production cultures 
yielded lower Qp with increasing cell age: 17 of the 24 cell lines displayed ≥20% Qp decrease within ~2-3 
months. This high frequency of Qp decline for these recombinant GS-CHO cell lines underscores the continued 
need for careful clone selection and for understanding the underlying mechanisms for Qp loss. Because our 
experiments were designed to decouple the effects of cryopreservation from those of cell age, we conclusively 
ruled out freeze-thaw as a cause for Qp decline.  
 
 
